Cargando…
Preparation of a Klebsiella pneumoniae conjugate nanovaccine using glycol-engineered Escherichia coli
BACKGROUND: Engineered strains of Escherichia coli have been used to produce bioconjugate vaccines using Protein Glycan Coupling Technology (PGCT). Nanovaccines have also entered the vaccine development arena with advances in nanotechnology and have been significantly developed, but chassis cells fo...
Autores principales: | Liu, Yan, Pan, Chao, Wang, Kangfeng, Guo, Yan, Sun, YanGe, Li, Xiang, Sun, Peng, Wu, Jun, Wang, Hengliang, Zhu, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163571/ https://www.ncbi.nlm.nih.gov/pubmed/37149632 http://dx.doi.org/10.1186/s12934-023-02099-x |
Ejemplares similares
-
Construction of Orthogonal Modular Proteinaceous Nanovaccine Delivery Vectors Based on mSA-Biotin Binding
por: Shi, Yixin, et al.
Publicado: (2022) -
Production of a Promising Biosynthetic Self‐Assembled Nanoconjugate Vaccine against Klebsiella Pneumoniae Serotype O2 in a General Escherichia Coli Host
por: Peng, Zhehui, et al.
Publicado: (2021) -
Enhancement of Immune Response of Bioconjugate Nanovaccine by Loading of CpG through Click Chemistry
por: Mo, Mengting, et al.
Publicado: (2023) -
A bioconjugate vaccine against Brucella abortus produced by engineered Escherichia coli
por: Li, Shulei, et al.
Publicado: (2023) -
Genetic Engineering of Klebsiella pneumoniae ATCC 25955 for Bioconjugate Vaccine Applications
por: Liu, Yan, et al.
Publicado: (2023)